Sox17 Antibody, anti-human, REAfinity™
Synonyms: Transcription factor SOX-17, SOX-17
RECOMBINANT
Bioz Star95/100 Bioz rating
11 Citations3 Images
Clone:
REA701 | P7-969
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for Sox17 Antibody, anti-human, REAfinity™

Intracellular flow cytometry applications
APC
PE
Vio B515
pure
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-111-033, 130-111-149
Description:
Human iPS cells differentiated into definitive endoderm were fixed and permeabilized using the FoxP3 Staining Buffer Set. Cells were then stained with Anti-Sox17 antibodies or with the corresponding REA Control (I) antibodies (left image) and analyzed by flow cytometry with the MACSQuant® Analyzer. Cell debris were excluded from the analysis based on scatter signals.

Application imageView details view details

Application imageView details view details
Specifications for Sox17 Antibody, anti-human, REAfinity™
Overview

Clone REA701 recognizes the human Sox17 antigen, a member of the SRY-related HMG-box family of transcription factors, which are implicated in embryogenesis. Sox17 is a transcription regulator that binds target promoter DNA and bends the DNA. Sox17 is found in adult heart, lung, spleen, testis, ovary, placenta, fetal lung, and kidney. In normal gastrointestinal tract, it is preferentially expressed in esophagus, stomach, and small intestine than in colon and rectum.

Additional information: Clone REA701 displays negligible binding to Fc receptors.

Alternative names

Transcription factor SOX-17, SOX-17

Detailed product information

Technical specifications

Clone
REA701
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
Sox17
Molecular mass of antigen [kDa]
44
Distribution of antigen
other, esophagus, heart, kidney, lung, placenta, ovary, spleen, testicle
Entrez Gene ID
RRID
AB_2653496, AB_2653495, AB_2653494, AB_2653493, AB_2653492, AB_2653497, AB_2653498

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for Sox17 Antibody, anti-human, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?